Evidence map›Paper›PMID 32342301›Full record

ArticleDoklady. Biochemistry and biophysics2020

Personalized Approach to Determination of Histidine-Rich Glycoprotein and E-Cadherin in Supernatants of Immunocompetent Blood Cells and Breast Biopsy Specimens in Breast Malignant and Non-Malignant Disease.

A I Autenshlyus, A V Bernado, A A Studenikina, A V Proskura, K I Davletova, I P Zhurakovskiy, S A Arkhipov, N A Varaksin, S V Sidorov, V V Lyakhovich

Abstract read
PubMed Publisher
In one paragraph

Article in Doklady. Biochemistry and biophysics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

A I AutenshlyusNovosibirsk State Medical University, Ministry of Health of the Russian Federation, Novosibirsk, Russia. lpciip@211.ru.
A V BernadoNovosibirsk State Medical University, Ministry of Health of the Russian Federation, Novosibirsk, Russia.
A A StudenikinaNovosibirsk State Medical University, Ministry of Health of the Russian Federation, Novosibirsk, Russia.
A V ProskuraResearch Institute of Molecular Biology and Biophysics, Novosibirsk, Russia.
K I DavletovaNovosibirsk State Medical University, Ministry of Health of the Russian Federation, Novosibirsk, Russia.
I P ZhurakovskiyNovosibirsk State Medical University, Ministry of Health of the Russian Federation, Novosibirsk, Russia.
S A ArkhipovNovosibirsk State Medical University, Ministry of Health of the Russian Federation, Novosibirsk, Russia.
N A VaraksinAO "Vector-Best", 630559, Koltsovo, Novosibirsk Region, Russia.
S V SidorovNational Research Novosibirsk State University, Novosibirsk, Russia.
V V LyakhovichResearch Institute of Molecular Biology and Biophysics, Novosibirsk, Russia.
Institute of Molecular Biology and Biophysics · RUNovosibirsk State Medical University · RUMinistry of Health of the Russian Federation · RUNovosibirsk State University · RUState Research Center of Virology and Biotechnology VECTOR · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The material of patients with invasive carcinoma of no special type (ICNT) and nonmalignant diseases (ND) of the mammary gland was studied. When comparing the concentrations of histidine-rich glycoprotein (HRG) and E-cadherin (CDH1), statistically significant differences between ICNT and ND by HRG in the supernatant of blood cells and its spontaneous production by biopsies and by CDH1 at its induced production, as well as by influence indices of polyclonal activators on the production of CDH1 were found. When comparing the expression of immunohistochemical markers, no statistically significant differences between ICNT and ND were obtained.

Indexed as

Antigens, CDBiomarkers, TumorBiopsyBreastBreast NeoplasmsCadherinsFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHistidine-Rich GlycoproteinHumansImmunohistochemistryProteinsAntigens, CDBiomarkers, TumorCadherinsCDH1 protein, humanHistidine-Rich GlycoproteinProteinsbreast diseasescadherin-Ehistidine-rich glycoproteinimmunohistochemical markersproteomics

Identifiers

PMID32342301
OpenAlexW3019628268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.